Phillip Nieburg

Phillip Nieburg, M.D., M.P.H., is a pediatrician, also trained in infectious diseases, who has worked in public health since 1977. He currently divides his professional time between Project HOPE, where he is a senior technical adviser on HIV/AIDS and tuberculosis, and CSIS, where he is senior associate with the HIV/AIDS Task Force. He also has adjunct faculty appointments at the University of Virginia’s Center for Biomedical Ethics and its Institute for Practical Ethics and Public Life. Dr. Nieburg received his undergraduate and M.D. degrees from Case Western Reserve University and a master of public health degree from Johns Hopkins University. After an internship at Children’s Hospital of Philadelphia and service as a U.S. Air Force pediatrician, he completed his pediatric and infectious disease training at the State University of New York’s Upstate Medical Center in Syracuse. Dr. Nieburg entered the Epidemic Intelligence Service at the Centers for Disease Control and Prevention (CDC) in 1977 and remained at CDC until 2003, serving most recently as associate director of CDC’s Global AIDS Program.

Posts by this staff member:

Report: Role(s) of Vaccines and Immunization Programs in Global Disease Prevention

This report focuses on the “nuts and bolts” of the complex biological, epidemiologic, and risk management concepts for currently available childhood vaccines.

Posts by this staff member:

Critical U.S Support will Help Mitigate the Global Impact of H1N1 (Swine) Flu

In our new segment, infectious disease experts will provide insights on different aspects of the unfolding H1N1 flu epidemic. For our first entry, Phillip Nieburg discusses the recent decision by the U.S. government to share 10 percent of its H1N1 vaccine supply with other nations. What questions do you have about H1N1?

Posts by this staff member:

Reproductive Health Choices for People Living with HIV/AIDS in Developing Countries

Since the early 1990s, many Americans have learned a lot about the cultures and health problems of various developing countries through reading and hearing about the spread and consequences of HIV/AIDS in those countries.

Posts by this staff member:

The Changing Standards for Anti-Retroviral Treatment of HIV/AIDS in Developing Countries

Infection with human immunodeficiency virus (HIV) causes severe illness and death through a slow but steady destruction of the immune system that progressively increases the risk of serious infection with other bacteria or viruses. The function of the immune system of people living with HIV/AIDS (PLWHA) is most easily measured by a blood test that counts the numbers of CD4 cells, the cells respons

Posts by this staff member:

HIV/AIDS, Vienna and the Ethics of Public Health

I have just left the ceremonial opening session of the 18th International AIDS Conference, an every-two-year global event being held this year in Vienna, Austria.

Posts by this staff member:

Planning for the Second Week and Beyond in Haiti

What happens when an emergency team is dispatched to the site of a natural disaster? CSIS Expert Phillip Nieburg provides insight into some of the questions and concerns that should be addressed during the early days of the relief effort in Haiti.

Posts by this staff member:

H1N1: Do We Know How Many People Have Been Infected?

Phillip Nieburg answers reader questions about H1N1 surveillance.

Posts by this staff member:

An Important Success in HIV Prevention Research – and the Need for a Lot More Work

The widely celebrated results of the vaginal microbicide study announced last week in Vienna are an important first step in the search for an HIV prevention method that can be controlled by women for effective prevention of sexual transmission.

Posts by this staff member:

Towards the MDGs: What Can be Done in the Next 5 Years

Here are three examples from a much longer "to do" list of how we can use the MDG efforts to begin serious progress towards public health goals.

Posts by this staff member:

Despite Progress, More Work is Needed to Control Infectious Diseases in Nigeria

A recent visit to an HIV/AIDS conference in Nigeria gave me an opportunity to review recent reports on several important infectious diseases in the country. The progress report was decidedly mixed.